Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,552 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,555
Recruiting: 1,937
Ph III recruiting: 226
Growth YoY: +16.9%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,964)

clinicaltrialsPublishedShowing 6,151–6,200 of 6,697 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00080795	Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium	completed	Phase 2	65	M.D. Anderson Cancer CenterOTHER	1	Oct 22, 2012	clinicaltrials
NCT00771966	Radical Prostatectomy and Perioperative Fluid Therapy	completed	Phase 4	44	Rigshospitalet, DenmarkOTHER	1	Oct 22, 2012	clinicaltrials